Positive list system on reimbursable drugs recommended

Published: 2004-09-03 07:00:00

Updated: 2004-09-03 07:00:00

The current negative list system of reimbursable drugs should be changed into the positive list system in the mid- and long-term, as part of undertaking the effective management of drug costs in the nation's healthcare expenditure, said an official from the Korea Health Insurance Development Comm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK